Summit Therapeutics shares owned by Barclays
Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Barclays
from 13F filings
Historical chart of Barclays investment in Summit Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Summit Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Summit Therapeutics by Barclays
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $9.8M | 476k | 20.66 |
| 2025-06-30 | $6.7M | 314k | 21.28 |
| 2025-03-31 | $4.9M | 256k | 19.29 |
| 2024-12-31 | $5.9M | 330k | 17.84 |
| 2024-09-30 | $5.5M | 250k | 21.89 |
| 2024-06-30 | $3.0M | 387k | 7.80 |
| 2024-03-31 | $1.6M | 393k | 4.14 |
| 2023-12-31 | $831k | 319k | 2.61 |
| 2023-09-30 | $277k | 148k | 1.87 |
| 2023-06-30 | $120k | 48k | 2.49 |
| 2023-03-31 | $432k | 247k | 1.75 |
| 2022-12-31 | $59k | 14k | 4.26 |
| 2022-09-30 | $0 | 2.1k | 0.00 |
| 2022-06-30 | $0 | 1.1k | 0.00 |
| 2022-03-31 | $11k | 4.4k | 2.57 |